Product Information

LAMOTRIGINE ER 50 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.5690 per EA under NDC 31722024130. Its NADAC has been published 193 times since Mar 15, 2023.

FDA first approved this application on Dec 8, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LAMOTRIGINE ER 50 MG TABLET

lamotrigine extended-release
$0.5690per EA

Strength

50 mg/1

NDC

31722024130

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA213949

FDA Approved

12/8/2021

TE Code

AB

On Market Since

12/9/2021

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMOTRIGINE ER 50 MG TABLET has been published 193 times since Mar 15, 2023, and over the history we have for it it has declined 52.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5690 per EA
All-time high$1.2336 (Sep 13, 2023)
All-time low$0.4730 (Nov 20, 2024)
52-week high$0.6996
52-week low$0.5125
Median price$0.7246
Average price$0.7639
Largest weekly change+66.9% (Aug 21, 2024)
Weeks tracked193
Tracking sinceMar 15, 2023

Price History

1W

+3.2%

1M

-4.2%

3M

+8.5%

6M

-8.9%

1Y

-10.1%

3Y

-52.9%

5Y

N/A

All

-52.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lamotrigine extended-release market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LAMOTRIGINE ER 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 50 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.5690 per EA (NDC 31722024130), effective Nov 18, 2026.

How has the price of LAMOTRIGINE ER 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMOTRIGINE ER 50 MG TABLET has declined 52.8%. It has been tracked across 193 weekly CMS publications since Mar 15, 2023.

What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 50 MG TABLET?

Since Mar 15, 2023, the NADAC for LAMOTRIGINE ER 50 MG TABLET has ranged from a low of $0.4730 (Nov 20, 2024) to a high of $1.2336 (Sep 13, 2023), with a median of $0.7246 per EA.

Are there cheaper alternatives to LAMOTRIGINE ER 50 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of LAMOTRIGINE ER 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LAMOTRIGINE ER 50 MG TABLET?

LAMOTRIGINE ER 50 MG TABLET (NDC 31722024130) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.